TTM Technologies Form 4: Clapprood Granted 7.9K RSUs, No Sales
Rhea-AI Filing Summary
TTM Technologies Inc. (TTMI) – Form 4 insider filing
On 24 June 2025, Tom Clapprood, President of the company’s Aerospace & Defense Interconnect Solutions segment, received 7,858 restricted stock units (RSUs) at a cost basis of $0.00. Following the grant, the executive beneficially owns 38,531 shares of common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of the grant date, with underlying shares deliverable within 30 days of each 24 June vesting milestone.
No shares were sold or otherwise disposed of, and the transaction was executed outside of any Rule 10b5-1 trading plan. This filing represents routine equity compensation intended to align management incentives with shareholder interests; it does not in itself signal a change in the company’s financial outlook.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine RSU grant; neutral impact on valuation.
The 7,858-share RSU award is standard annual compensation and equals only a fraction of TTMI’s ~100 million shares outstanding, so dilution is de minimis. No purchase with insider cash occurred, therefore no incremental bullish signal. The three-year vesting schedule promotes retention and long-term alignment but does not alter near-term financial metrics.
TL;DR: Governance-friendly equity award; immaterial for investors.
The grant follows common practice for senior executives and includes multi-year vesting, which encourages continuity and discourages short-term risk-taking. There is no evidence of opportunistic timing or Rule 10b5-1 reliance. Overall, the filing is administratively sound and carries neutral market impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,858 | $0.00 | -- |
Footnotes (1)
- [object Object]
FAQ
What is the vesting schedule for the new TTMI RSUs?
What is Tom Clapprood’s total beneficial TTMI ownership after the transaction?
Does this Form 4 filing involve a Rule 10b5-1 trading plan?